Monte Rosa Therapeutics, Inc. (GLUE) Nonoperating Income (Expense) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Monte Rosa Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
  • Monte Rosa Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.06 M, a 37.9% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $9.14 M, a 59.4% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $8.3 M, a 114% increase from 2022.
  • Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $3.88 M.
  • Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.08 M, a 86.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.14 M $3.06 M +$841 K +37.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.3 M $1.59 M -$118 K -6.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $8.42 M $2.25 M +$1.21 M +116% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.21 M $2.23 M +$1.47 M +193% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.73 M $2.22 M +$1.85 M +500% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.88 M $1.71 M +$1.76 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.12 M $1.04 M +$1.01 M +3268% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.11 M $762 K +$1.04 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $66 K $370 K +$1.14 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$1.08 M -$53 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $31 K +$203 K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$282 K -$314 K -981% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$772 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$172 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $32 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.